{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:37:52Z","timestamp":1793831872228,"version":"4.6.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transcatheter mitral valve replacement (TMVR) has emerged as alternative to transcatheter edge-to-edge repair (TEER) for treatment of mitral regurgitation (MR); however, the role of TMVR with the Tendyne system among established treatments of MR is not well defined. We assessed characteristics and outcomes of patients treated with the Tendyne system in the current clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We reviewed patients who underwent cardiac computed tomography and were judged eligible for the Tendyne system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 63 patients were eligible for TMVR with the Tendyne system. Of these, 17 patients underwent TMVR, and 46 were treated by TEER. Patients treated with the Tendyne system were more likely to have a high transmitral pressure gradient and unsuitable mitral valve morphology for TEER than those treated with TEER. TMVR with the Tendyne system reduced the severity of MR to less than 1\u2009+\u2009in 94.1% of the patients at discharge and achieved a greater reduction in left ventricular (LV) end-diastolic volume at the 30-day follow-up compared with TEER. In contrast, patients treated with the Tendyne system had a higher 30-day mortality than those treated with TEER, while the mortality between 30\u00a0days and one year was comparable between Tendyne and TEER.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Among patients eligible for the Tendyne system, approximately a quarter of the patients underwent TMVR with the Tendyne system, which led substantial reduction of MR and LV reverse remodeling than TEER. In contrast, the 30-day mortality rate was higher after TMVR with the Tendyne compared to TEER.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00392-023-02155-x","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T13:03:25Z","timestamp":1673874205000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics and outcomes of patients undergoing transcatheter mitral valve replacement with the Tendyne system"],"prefix":"10.1007","volume":"113","author":[{"given":"Nihal","family":"Wilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-8689","authenticated-orcid":false,"given":"Tetsu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Vij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsumasa","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Eicheler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Silaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Vogelhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Bakhtiary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"2155_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","volume":"391","author":"V Dziadzko","year":"2018","unstructured":"Dziadzko V, Clavel M-A, Dziadzko M et al (2018) Outcome and undertreatment of mitral regurgitation: a community cohort study. The Lancet 391:960\u2013969","journal-title":"The Lancet"},{"key":"2155_CR2","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143:e72\u2013e227","journal-title":"Circulation"},{"key":"2155_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","volume":"60","author":"A Vahanian","year":"2021","unstructured":"Vahanian A, Beyersdorf F, Praz F et al (2021) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 60:727\u2013800","journal-title":"Eur J Cardiothorac Surg"},{"key":"2155_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12928-022-00898-4","volume":"38","author":"A Kataoka","year":"2023","unstructured":"Kataoka A, Watanabe Y, Family O-S (2023) MitraClip: a review of its current status and future perspectives. Cardiovasc Interv Ther 38:28\u201338","journal-title":"Cardiovasc Interv Ther"},{"key":"2155_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0395-7","author":"B Del Forno","year":"2020","unstructured":"Del Forno B, De Bonis M, Agricola E et al (2020) Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-020-0395-7","journal-title":"Nat Rev Cardiol"},{"key":"2155_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/24748706.2021.1902595","volume":"5","author":"DS Lim","year":"2021","unstructured":"Lim DS, Herrmann HC, Grayburn P et al (2021) Consensus document on non-suitability for transcatheter mitral valve repair by edge-to-edge therapy. Str Heart 5:227\u2013233","journal-title":"Str Heart"},{"key":"2155_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2492","author":"WB Ali","year":"2022","unstructured":"Ali WB, Ludwig S, Duncan A et al (2022) Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-Year results from the CHOICE-MI Registry. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2492","journal-title":"Eur J Heart Fail"},{"key":"2155_CR8","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1016\/j.jacc.2021.04.051","volume":"77","author":"A Alperi","year":"2021","unstructured":"Alperi A, Granada JF, Bernier M et al (2021) Current status and future prospects of transcatheter mitral valve replacement: JACC State-of-the-art review. J Am Coll Cardiol 77:3058\u20133078","journal-title":"J Am Coll Cardiol"},{"key":"2155_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2018.12.066","volume":"73","author":"P Sorajja","year":"2019","unstructured":"Sorajja P, Moat N, Badhwar V et al (2019) Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol 73:1250\u20131260","journal-title":"J Am Coll Cardiol"},{"key":"2155_CR10","unstructured":"Wild MG, Kreidel F, Hell MM, et al. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience. Eur J Heart Fail 2022"},{"key":"2155_CR11","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jacc.2021.08.060","volume":"78","author":"DWM Muller","year":"2021","unstructured":"Muller DWM, Sorajja P, Duncan A et al (2021) 2-Year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation. J Am Coll Cardiol 78:1847\u20131859","journal-title":"J Am Coll Cardiol"},{"key":"2155_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jcmg.2020.03.013","volume":"13","author":"M Guerrero","year":"2020","unstructured":"Guerrero M, Wang DD, Pursnani A et al (2020) A cardiac computed tomography-based score to categorize mitral annular calcification severity and predict valve embolization. JACC Cardiovasc Imaging 13:1945\u20131957","journal-title":"JACC Cardiovasc Imaging"},{"key":"2155_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F et al (2022) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43:561\u2013632","journal-title":"Eur Heart J"},{"key":"2155_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcin.2019.04.034","volume":"12","author":"DS Lim","year":"2019","unstructured":"Lim DS, Kar S, Spargias K et al (2019) Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP Study. JACC Cardiovasc Interv 12:1369\u20131378","journal-title":"JACC Cardiovasc Interv"},{"key":"2155_CR15","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.jcin.2019.03.023","volume":"12","author":"F Praz","year":"2019","unstructured":"Praz F, Braun D, Unterhuber M et al (2019) Edge-to-edge mitral valve repair with extended clip arms: early experience from a multicenter observational study. JACC Cardiovasc Interv 12:1356\u20131365","journal-title":"JACC Cardiovasc Interv"},{"key":"2155_CR16","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/eurheartj\/ehv333","volume":"36","author":"GW Stone","year":"2015","unstructured":"Stone GW, Adams DH, Abraham WT et al (2015) Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions. Eur Heart J 36:1878\u20131891","journal-title":"Eur Heart J"},{"key":"2155_CR17","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1093\/ehjci\/jeab253","volume":"23","author":"P Lancellotti","year":"2022","unstructured":"Lancellotti P, Pibarot P, Chambers J et al (2022) Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 23:e171\u2013e232","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2155_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00392-013-0614-x","volume":"103","author":"P Boekstegers","year":"2014","unstructured":"Boekstegers P, Hausleiter J, Baldus S et al (2014) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103:85\u201396","journal-title":"Clin Res Cardiol"},{"key":"2155_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2188\/jea.JE20210145","volume":"31","author":"K Shiba","year":"2021","unstructured":"Shiba K, Kawahara T (2021) Using propensity scores for causal inference: pitfalls and tips. J Epidemiol 31:457\u2013463","journal-title":"J Epidemiol"},{"key":"2155_CR20","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.jcin.2020.06.009","volume":"13","author":"M Fukui","year":"2020","unstructured":"Fukui M, Sorajja P, Gossl M et al (2020) Left ventricular remodeling after transcatheter mitral valve replacement with tendyne: new insights from computed tomography. JACC Cardiovasc Interv 13:2038\u20132048","journal-title":"JACC Cardiovasc Interv"},{"key":"2155_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ehjci\/jey088","volume":"20","author":"HJ Brouwer","year":"2019","unstructured":"Brouwer HJ, Den Heijer MC, Paelinck BP et al (2019) Left ventricular remodelling patterns after MitraClip implantation in patients with severe mitral valve regurgitation: mechanistic insights and prognostic implications. Eur Heart J Cardiovasc Imaging 20:307\u2013313","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2155_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ejhf.1343","volume":"21","author":"M Adamo","year":"2019","unstructured":"Adamo M, Godino C, Giannini C et al (2019) Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail 21:196\u2013204","journal-title":"Eur J Heart Fail"}],"updated-by":[{"DOI":"10.1007\/s00392-023-02174-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000}}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02155-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02155-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02155-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:19:50Z","timestamp":1719911990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02155-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02155-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00392-023-02174-8","asserted-by":"object"}]},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary material was mentioned in the text but it was not provided. Hence the article was published without the supplementary material. This has now been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00392-023-02174-8","URL":"https:\/\/doi.org\/10.1007\/s00392-023-02174-8","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tetsu Tanaka has been financially supported in part by a Fellowship from the Japanese College of Cardiology and the Uehara Memorial Foundation. Atsushi Sugiura has received honoraria for lectures from Edwards Lifesciences. Georg Nickenig and Sebastian Zimmer have received research funding from the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research, the EU, Abbott, Edwards Lifesciences, and Medtronic, and have received honoraria for lectures or advisory boards from Abbott, Edwards Lifesciences, and Medtronic. Marcel Weber has received lecture or proctoring fees from Abbott and Edwards Lifesciences. Miriam Silaschi has received a research grant from Medtronic. The other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}